Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Feasibility Assessment of Adapted Physical Activity in Patients Treated for a Brain Tumor (APATC)

30 aprile 2026 aggiornato da: Center Eugene Marquis

The goal of this clinical trial is to assess the feasibility of an adapted physical activity (APA) program in adult patients (≥18 years) with primary brain tumors, regardless of tumor type, grade, treatment stage, or the presence of motor, sensory, attention, concentration, or memory deficits.

The main question it aims to answer is:

What is the effective adherence rate to an APA program among eligible patients with primary brain tumors?

Additional questions include:

  • What is the observance rate (number of sessions completed, intensity achieved, and duration) during the 3-month supervised APA program?
  • What is the retention rate (proportion of patients completing the program and continuing APA beyond the initial period)?
  • What is the impact of APA on quality of life, anxiety-depression, and cancer-related symptoms (measured via QLQ-BN20, HADS, and MFI-20 questionnaires at baseline, 3, and 4 months)?

Participants will:

  • Undergo a 3-month supervised APA program (with possible continuation beyond this period).
  • Use connected watches to monitor physical activity (if they accept the general conditions of use).
  • Complete self-questionnaires (IPAQ, BREQ-2, QPP, QLQ-BN20, HADS, MFI-20) at inclusion, 3 months, and 4 months.
  • Be followed for a total of 4 months after inclusion.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

90

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

  • Francia
      • Rennes, Francia, 35000
        • Centre Eugene Marquis
        • Contatto:
        • Investigatore principale:
          • Elodie VAULEON, DR

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Men or women ≥ 18 years old,
  • Receiving medical oncology treatment at the CLCC Eugène Marquis,
  • Diagnosed with a primary brain tumour, regardless of diagnosis, grade or treatment,
  • Possible motor, sensory, attention, concentration, or memory deficits,
  • Patients who accept the general terms of use for connected watches
  • Patients affiliated with or covered by the French social security system,
  • Patients who have received information and signed informed consent (or their legal representative),

Exclusion Criteria:

  • WHO score ≥ 3
  • Comprehension disorders that prevent participation in adapted physical activity
  • Pregnant or breastfeeding women
  • Patients without the necessary devices to use a smartwatch (smartphone, tablet or computer),
  • Patients deprived of liberty, under guardianship, or curatorship, or subject to any other administrative safeguard measure.

Patients unable to comply with the study schedule for social, medical, or psychological reasons.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione di gruppo singolo
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: PA with Strength Sheets + Walking Recommendation
Patients receive 2 strength exercise sheets to perform weekly at home + a recommendation to walk regularly (30 min/day). No supervised sessions. Activity is self-monitored via connected watch.
Altro: adapted physical activity
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.
Sperimentale: APA with Strength Sheet + Group Videoconference Session
Patients receive 1 strength exercise sheet to perform weekly at home + 1 hour of group training via videoconference per week. The videoconference session content matches the 2nd strength sheet from Arm 1. Activity is self-monitored via connected watch.
Altro: adapted physical activity
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.
Sperimentale: APA with Strength Sheet + Individual Home Session
Patients receive 1 strength exercise sheet to perform weekly at home + 1 hour of individualized and personalized training at home per week. The home session content matches the 2nd strength sheet from Arm 1. Activity is self-monitored via connected watch.
Altro: adapted physical activity
Adapted Physical Activity (APA) is a tailored exercise program designed for individuals with specific health conditions, such as brain tumors. It aims to improve physical function, quality of life, and overall well-being while ensuring safety and feasibility. APA is supervised by trained professionals and adapted to each individual's abilities and needs.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Effective adherence rate to the Adapted Physical Activity (APA) program
Lasso di tempo: Baseline to 4 months
The primary outcome is the proportion of eligible patients who participate in at least one APA session out of the total number of eligible patients solicited for inclusion. This metric Evaluates the feasibility of APA implementation in brain tumor patients.
Baseline to 4 months

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
APA program observance rate
Lasso di tempo: Baseline to 4 months
Evaluated through the number of sessions completed, the number of sessions reaching the recommended intensity level, and the duration of sessions performed during the 3-month supervised period and the 1-month autonomous period.
Baseline to 4 months
Retention rate during the 3-month supervised APA period
Lasso di tempo: Baseline to 3 months
Proportion of patients who complete the entire 3-month supervised APA program, reflecting their commitment and ability to sustain participation.
Baseline to 3 months
Retention Rate After Supervised APA Period
Lasso di tempo: 4 months
Proportion of patients who continue APA beyond the initial 3-month supervised period, assessed at 4 months.
4 months
Reasons for early discontinuation of APA
Lasso di tempo: Baseline to 4 months
Documentation of specific reasons (e.g., fatigue, disease progression, lack of motivation) for patients who discontinue APA prematurely.
Baseline to 4 months
uality of life assessment using QLQ-BN20 questionnaire (EORTC Quality of Life Questionnaire - Brain Neoplasm Module 20)
Lasso di tempo: Baseline, 3 months, and 4 months
Evaluation of brain tumor-specific quality of life using the EORTC QLQ-BN20 questionnaire, which assesses symptoms and functional domains relevant to brain tumor patients.
Baseline, 3 months, and 4 months
Anxiety and depression assessment using HADS (Hospital Anxiety and Depression Scale) questionnaire
Lasso di tempo: Baseline, 3 months, and 4 months
Evaluation of anxiety and depression levels using the Hospital Anxiety and Depression Scale (HADS), a validated tool for assessing psychological distress.
Baseline, 3 months, and 4 months
Fatigue assessment using MFI-20 (Multidimensional Fatigue Inventory-20) questionnaire
Lasso di tempo: Baseline, 3 months, and 4 months
Evaluation of multidimensional fatigue (general, physical, mental, reduced motivation, and reduced activity) using the Multidimensional Fatigue Inventory (MFI-20).
Baseline, 3 months, and 4 months
Physical activity level assessment using IPAQ (International Physical Activity Questionnaire) questionnaire
Lasso di tempo: Baseline, 3 months, and 4 months
Evaluation of physical activity intensity and frequency using the International Physical Activity Questionnaire (IPAQ), which classifies participants into low, moderate, or high activity levels.
Baseline, 3 months, and 4 months
Motivation for physical activity assessment using BREQ-2 -Behavioral Regulation in Exercise Questionnaire - Version 2) questionnaire
Lasso di tempo: Baseline, 3 months, and 4 months
Evaluation of motivation types (intrinsic, identified, introjected, external) using the Behavioral Regulation in Exercise Questionnaire (BREQ-2).
Baseline, 3 months, and 4 months
Perceived enjoyment of physical activity assessment using PACES (Physical Activity Enjoyment Scale) questionnaire
Lasso di tempo: Baseline, 3 months, and 4 months
Evaluation of enjoyment and satisfaction related to physical activity using the PACES questionnaire.
Baseline, 3 months, and 4 months

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Center Eugene Marquis

Collaboratori

University of Rennes 2

Investigatori

  • Investigatore principale: Elodie VAULEON, Dr, Centre de lutte contre le cancer Eugène Marquis

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 giugno 2026

Completamento primario (Stimato)

1 giugno 2028

Completamento dello studio (Stimato)

1 giugno 2028

Date di iscrizione allo studio

Primo inviato

30 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

30 aprile 2026

Primo Inserito (Effettivo)

6 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

6 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 aprile 2026

Ultimo verificato

1 aprile 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 2025-4-79-002

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Tumore al cervello adulto

Prove cliniche su adapted physical activity

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in Mauritania

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

Sottoscrivi